Shots: Lily and BI reports results of EMPA-REG OUTCOME trial assessing Jardiance (10/25 mg qd) vs PBO, from 42 countries in 7,020 patients with T2D at high risk for cardiovascular […]readmore
Tags : Jardiance (empagliflozin)